Atara Biotherapeutics (ATRA) EPS (Basic) (2013 - 2026)
Atara Biotherapeutics (ATRA) posted EPS (Basic) of -$0.29 for Q1 2026, down 8.99% on a QoQ basis from -$0.27 in Q4 2025, and down 108.34% year-over-year from $3.53 in Q1 2025.
Atara Biotherapeutics (ATRA) EPS (Basic) (2013 - 2026) Analysis & Trends
Atara Biotherapeutics' EPS (Basic) history runs 14 years deep, the most recent figure standing at -$0.29 for Q1 2026.
- Quarterly EPS (Basic) fell 108.34% year-over-year to -$0.29 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$0.67 (up 53.82% YoY) and the FY2025 annual result came in at $2.61, up 122.86% from the prior year.
- EPS (Basic) was -$0.29 for Q1 2026 at Atara Biotherapeutics, down from -$0.27 in the prior quarter.
- Across five years, EPS (Basic) topped out at $4.54 in Q2 2022 and bottomed at -$21.87 in Q1 2022.
- A 5-year average of -$7.78 and a median of -$3.1 in 2024 frame the typical range for EPS (Basic).
- Annual changes were most pronounced in 2023 — EPS (Basic) tumbled 472.29% — and 2025, when it soared 162.54%.
- Atara Biotherapeutics' EPS (Basic) stood at -$18.28 in 2022, then rose by 21.94% to -$14.27 in 2023, then soared by 88.12% to -$1.7 in 2024, then soared by 84.07% to -$0.27 in 2025, then decreased by 8.99% to -$0.29 in 2026.
- Business Quant data shows ATRA's EPS (Basic) at -$0.29 in Q1 2026, -$0.27 in Q4 2025, and -$0.32 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 0.00 |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 0.16 |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | 0.00 |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 7.59 |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | -2.29 |
| 10 | Atara Biotherapeutics | 110.04 Mn | 101.68 Mn | 392,000.00 | -0.29 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.29 |
| Dec 31, 2025 | -0.27 |
| Sep 30, 2025 | -0.32 |
| Jun 30, 2025 | 0.20 |
| Mar 31, 2025 | 3.53 |
| Dec 31, 2024 | -1.70 |
| Sep 30, 2024 | -2.93 |
| Jun 30, 2024 | -3.10 |
| Mar 31, 2024 | -5.65 |
| Dec 31, 2023 | -14.27 |
| Sep 30, 2023 | -16.40 |
| Jun 30, 2023 | -16.92 |
| Mar 31, 2023 | -17.98 |
| Dec 31, 2022 | -18.28 |
| Sep 30, 2022 | -20.53 |
| Jun 30, 2022 | 4.54 |
| Mar 31, 2022 | -21.87 |
| Dec 31, 2021 | -24.97 |
| Sep 30, 2021 | -22.61 |
| Jun 30, 2021 | -22.73 |